UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Amendment No. 2 to

Form 10-QSB

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2002

¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF  THE THE SECURITIES EXCHANGE ACT

For the transition period from                  to                 

Commission file number 000-27915

MOBILE PET SYSTEMS, INC.

A Delaware Corporation

(Exact name of small business issuer as specified in its charter)

DELAWARE	11-2787966
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

2150 West Washington Street, Suite 110

San Diego, California 92110

(Address of principal executive offices)

(619) 226-6738

(Issuer’s telephone number)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes    x    No    ¨

There were 44,251,333 shares outstanding of the issuer’s Common Stock as of April 30, 2002.

Transitional Small Business Disclosure Format (Check one):    Yes    ¨    No    x

Explanatory Note

This Amendment No. 2 to Form 10-QSB for the three month period ended March 31, 2002 is being filed to restate the financial statements as of March 31, 2002 and the three and nine month periods then ended. This restatement (i) corrects the reported value of certain stock compensation, (ii) records a noncash credit for options forfeited, and (iii) re-classifies certain expenses between selling and marketing expense, and general and administrative expense. The Company is amending this filing to allow for period-by-period comparisons using consistently applied accounting classifications.

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

For the quarterly period ended March 31, 2002

Table of Contents

	Page No.
PART I.    FINANCIAL INFORMATION
Item 1.    Financial Statements (unaudited)	1
Consolidated Balance Sheets as of March 31, 2002 and 2001	1
Consolidated Statements of Operations For the Three and Nine Months Ended March 31, 2002 and 2001	2
Consolidated Statements of Changes in Shareholders’ Equity	3
Consolidated Statements of Cash Flows	6
Notes to Consolidated Financial Statements	7
Item 2.    Management’s Discussion and Analysis	19
PART II.    OTHER INFORMATION
Item 1.    Legal Proceedings	30
Item 2.    Changes in Securities	31
Item 4.    Submission of Matters to a Vote of Security Holders	32
Item 6.    Exhibits and Reports on Form 8-K	32
Signatures	33

PART I.    FINANCIAL INFORMATION

Item 1.    Financial Statements (unaudited)

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

March 31, 2002 and 2001

(Unaudited)

	2002			2001
ASSETS
Current assets
Cash	$	331,170		$	2,091
Accounts receivable, net of allowance for doubtful accounts of $129,320 at March 31, 2002 and 2001		2,853,117			2,225,351
Prepaid expenses and other receivables		779,650			234,766
Deposits and other assets		1,030,611			842,616
Total current assets		4,994,548			3,304,824
Property and equipment, net		15,667,824			18,033,487
Other assets
Accrued interest receivable		10,573			10,573
Due from London Radiosurgical Centre, Ltd		152,924			252,369
Subordinated equity participation		200,000			200,000
Restricted cash		351,065			341,780
Total assets	$	21,376,934		$	22,143,033
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	3,986,504		$	3,191,496
Current portion of note payable		15,284			22,711
Loan payable		509,050			1,225,000
Accrued and other liabilities		2,005,904			467,257
Obligations under capital lease—current		8,523,552			3,693,640
Total current liabilities		15,040,294			8,600,104
Noncurrent liabilities
Obligations under capital lease		5,519,999			14,861,981
Note payable		63,147			86,042
Total liabilities		20,623,440			23,548,127
Shareholders’ equity (deficit)
Preferred stock; $0.001 par value; 10,000,000 shares authorized:
Preferred stock; Series A; 23 and 39 shares issued and outstanding at March 31, 2002 and 2001, respectively		1,351,030			1,975,000
Preferred stock; Series B; 30 and 30 shares issued and outstanding at March 31, 2002 and 2001, respectively		1,768,103			1,500,000
Common stock; $0.0001 par value; 90,000,000 shares authorized; 41,822,762 and 17,716,284 shares issued and outstanding at March 31, 2002 and 2001, respectively		4,182			1,772
Additional paid in capital		19,775,386			11,061,377
Accumulated deficit		(21,872,428	)		(15,901,559	)
Foreign currency translation adjustment		(272,779	)		(41,684	)
Total shareholders’ equity (deficit)		753,494			(1,405,094	)
Total liabilities and shareholders’ equity (deficit)	$	21,376,934		$	22,143,033

1

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

For the Three and Nine Months Ended March 31, 2002 and 2001

(Unaudited)

	Three Months Ended March 31,						Nine Months Ended March 31,
	2002			2001			2002			2001
Service revenues	$	4,599,403		$	2,308,196		$	12,427,453		$	4,267,864
Cost of service revenues		2,885,556			1,452,592			7,504,646			3,197,848
Gross profit		1,713,847			855,604			4,922,807			1,070,016
Expenses
Selling and marketing		363,637			978,017			1,134,555			2,740,637
General and administrative		1,979,766			1,164,367			5,645,185			4,146,550
Total expenses		2,343,403			2,142,384			6,779,740			6,887,187
Loss from operations		(629,556	)		(1,286,780	)		(1,856,933	)		(5,817,171	)
Other income (expense)
Interest income		1,639			4,058			6,765			29,047
Other income (expense)		(12,400	)		1,702			(24,598	)		(4,662	)
Interest expense		(521,444	)		(676,196	)		(1,628,265	)		(1,620,831	)
Total other income (expense)		(532,205	)		(670,436	)		(1,646,098	)		(1,596,446	)
Loss before provision for income taxes		(1,161,761	)		(1,957,216	)		(3,503,031	)		(7,413,617	)
Provision for income taxes		—			5,897			1,600			5,897
Net loss		(1,161,761	)		(1,963,113	)		(3,504,631	)		(7,419,514	)
Preferred stock dividend		61,618			29,000			214,305			683,481
Net loss—available to common shareholders	$	(1,223,379	)	$	(1,992,113	)	$	(3,718,936	)	$	(8,102,995	)
Net loss—available to common shareholders—basic	$	(0.03	)	$	(0.12	)	$	(0.12	)	$	(0.52	)
Net loss—available to common shareholders—diluted	$	(0.03	)	$	(0.12	)	$	(0.12	)	$	(0.52	)

See accompanying notes.

2

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

Consolidated Statements of Changes in Shareholders’ Equity

(Unaudited)

	Preferred Stock					Common Stock			Additional Paid In Capital			Accumulated Deficit			Foreign Currency Translation Adjustment			Total Shareholders’ Equity
	Shares		Amount			Shares	Amount
Balance—June 30, 2000	60		$	3,000,000		14,944,658	$	1,495	$	8,580,888		$	(8,415,771	)	$	(42,938	)	$	3,123,674
Preferred stock issued in private placement, net of offering costs	20			1,000,000						(115,000	)								885,000
Stock subscribed, net of offering costs										547,500									547,500
Noncash charge for stock options issued										92,331									92,331
Net loss—July 1, 2000 to September 30, 2000													(2,263,027	)					(2,263,027	)
Foreign currency translation adjustment																73,143			73,143
Balance—September 30, 2000	80			4,000,000		14,944,658		1,495		9,105,719			(10,678,798	)		30,205			2,458,621
Preferred stock issued in private placement, net of offering costs	10			500,000						(500,000	)								—
Common stock issued through conversion of preferred stock	(18	)		(875,000	)	692,158		68		874,932									—
Common stock issued through conversion of preferred stock dividend						75,356		8		66,266			(66,274	)					—
Common stock issued from subscriptions paid, net of offering costs						25,000		3		(3	)								—
Noncash charge for stock options issued										92,331									92,331
Common stock subscribed, net of offering costs										500,000									500,000
Net loss—October 1, 2000 to December 31, 2000													(3,193,374	)					(3,193,374	)
Foreign currency translation adjustment																31,068			31,068
Balance—December 31, 2000	72			3,625,000		15,737,172		1,574		10,139,245			(13,938,446	)		61,273			(111,354	)
Common stock issued in private placement, net of offering costs						1,590,584		159		324,841									325,000
Common stock issued through conversion of preferred stock dividend	(3	)		(150,000	)	388,528		39		149,961									—
Noncash charge for stock options issued										439,530									439,530
Convertible debt intrinsic beneficial conversion feature										7,800									7,800
Net loss—January 1, 2001 to March 31, 2001													(1,963,113	)					(1,963,113	)
Foreign currency translation adjustment																(102,957	)		(102,957	)

See accompanying notes.

3

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

Consolidated Statements of Changes in Shareholders’ Equity

(Unaudited)

	Preferred Stock				Common Stock		Additional Paid In Capital		Accumulated Deficit		Foreign Currency Translation Adjustment		Total Shareholders’ Equity
	Shares		Amount		Shares	Amount
Balance—March 31, 2001	69		3,475,000		17,716,284	1,772	11,061,377		(15,901,559	)	(41,684	)	(1,405,094	)
Preferred stock issued in private placement net of offering costs recapitalization of preferred stock			621,456				(347,500	)	(273,956	)			—
Common stock issued in private placement, net of offering costs					2,147,578	216	995,934						996,150
Common stock issued through conversion of preferred stock	(5	)	(295,035	)	607,893	60	294,975						—
Common stock issued through conversion of debt					1,875,000	188	749,812						750,000
Common stock issued through settlement agreement					2,733,981	273	749,727						750,000
Common stock subscribed, net of offering costs							1,000,000						1,000,000
Common stock issued for services					403,350	40	201,635						201,675
Noncash credit for stock options issued							(210,277	)					(210,277	)
Net loss—April 1, 2001 to June 30, 2001									(2,192,282	)			(2,192,282	)
Foreign currency translation adjustment											(278,673	)	(278,673	)
Balance—June 30, 2001	64		3,801,421		25,484,086	2,549	14,495,683		(18,367,797	)	(320,357	)	(388,501	)
Common stock issued from subscriptions paid, net of offering costs					2,600,000	260	(260	)					—
Common stock issued in private placement, net of offering costs					4,014,285	401	1,404,599						1,405,000
Common stock issued as finders fee					100,000	10	(10	)					—
Common stock issued for compensation					100,000	10	42,990						43,000
Noncash credit for stock options issued							(75,604	)					(75,604	)
Noncash charge for stock warrants issued							19,667						19,667
Common stock issued for services					325,967	33	125,218						125,251
Net loss—July 1, 2001 to September 30, 2001									(1,056,317	)			(1,056,317	)
Foreign currency translation adjustment											(12,652	)	(12,652	)

See accompanying notes.

4

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

Consolidated Statements of Changes in Shareholders’ Equity

(Unaudited)

	Preferred Stock					Common Stock			Additional Paid In Capital			Accumulated Deficit			Foreign Currency Translation Adjustment			Total Shareholders’ Equity
	Shares		Amount			Shares	Amount
Balance—September 30, 2001	64			3,801,421		32,624,338		3,263		16,012,283			(19,424,114	)		(333,009	)		59,844
Common stock issued in private placement, net of offering costs						2,728,571		273		1,119,727									1,120,000
Common stock issued through conversion of preferred stock	(2	)		(117,874	)	221,328		22		117,852									—
Common stock issued as finders fee						61,714		6		(6	)								—
Noncash credit for stock options issued										(515,510	)								(515,510	)
Noncash charge for stock warrants issued										196,690									196,690
Common stock issued for services						2,600,000		260		874,740									875,000
Net loss—October 1, 2001 to December 31, 2001													(1,286,553	)					(1,286,553	)
Foreign currency translation adjustment																1,727			1,727
Balance—December 31, 2001	62			3,683,547		38,235,951		3,824		17,805,776			(20,710,667	)		(331,282	)		451,198
Common stock issued in private placement net of offering costs						1,928,571		193		749,807									750,000
Stock subscriptions paid										500,000									500,000
Common stock issued through conversion of preferred stock	(9	)		(564,414	)	1,521,876		152		564,262									—
Common stock issued for services						136,364		13		59,987									60,000
Noncash charge for stock options issued										95,554									95,554
Net loss—January 1, 2002 to March 31, 2002													(1,161,761	)					(1,161,761	)
Foreign currency translation adjustment																58,503			58,503
Balance—March 31, 2002	53		$	3,119,133		41,822,762	$	4,182	$	19,775,386		$	(21,872,428	)	$	(272,779	)	$	753,494

See accompanying notes.

5

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

	Three Months Ended March 31,						Nine Months Ended March 31,
	2002			2001			2002			2001
Cash flows from operating activities
Net loss	$	(1,161,761	)	$	(1,963,113	)	$	(3,504,631	)	$	(7,419,514	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities
Depreciation		763,413			741,586			2,277,766			1,583,108
Common stock issued for compensation		—			—			43,000			—
Common stock issued for services		60,000			—			1,060,251			—
Interest		—			7,800			—			55,308
Noncash stock option and warrant (credit) charge		95,554			439,530			(279,203	)		624,192
(Increase) decrease in operating assets
Accounts receivable		(387,846	)		(1,417,224	)		(796,365	)		(1,752,618	)
Due from London Radiosurgical Center, LTD		(24,887	)		63,332			85,642			182,731
Prepaid expenses and other receivables		193,358			(174,349	)		62,829			315,159
Deposits and other assets		(527,200	)		(23,008	)		(548,650	)		474,348
Restricted cash		(1,505	)		(4,057	)		(6,195	)		(12,300	)
Accrued interest receivable		—			—			—			(15,124	)
Increase (decrease) in operating liabilities
Accounts payable		1,304,841			957,891			1,482,995			2,518,556
Accrued and other liabilities		1,082,771			214,455			970,108			(22,110	)
Net cash provided by (used in) operating activities		1,396,738			(1,157,157	)		847,547			(3,468,264	)
Cash flows from investing activities
Capital expenditures		(103,988	)		—			(236,598	)		(162,966	)
Net cash (used in) investing activities		(103,988	)		—			(236,598	)		(162,966	)
Cash flows from financing activities
Cash overdraft		—			9,506			—			34,440
Proceeds from loan		—			925,000			—			1,333,753
Repayments of loans		(58,221	)		—			(155,995	)		—
Payments on obligations under capital lease		(2,315,544	)		—			(4,009,442	)		(514,659	)
Preferred stock issued		—			—			—			1,385,000
Common stock issued		1,250,000			325,000			3,775,000			872,500
Net cash provided by (used in) financing activities		(1,123,765	)		1,259,506			(390,437	)		3,111,034
Effect of exchange rate on changes in cash		95,272			(102,957	)		47,578			1,254
Net increase (decrease) in cash		264,257			(608	)		268,090			(518,942	)
Cash—beginning of period		66,913			2,699			63,080			521,033
Cash—end of period	$	331,170		$	2,091		$	331,170		$	2,091
Supplemental disclosures
Interest paid	$	521,444		$	872,104		$	1,627,671		$	1,299,963
Income taxes paid	$	12,400		$	5,897		$	26,414		$	5,897
Noncash investing and financing activities
Equipment under capital lease	$	—		$	11,897,064		$	—		$	13,330,927
Obligations under capital lease	$	—		$	11,897,064		$	—		$	13,330,927

See accompanying notes.

6

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1—The Company

Mobile PET Systems, Inc. and subsidiaries (the “Company”) were organized to provide Positron Emission Tomography (“PET”) systems and services to hospitals and other health care providers on a mobile, shared user basis. The Company’s PET services include the provision of high technology imaging systems, technologists to operate the imaging systems, the management of day-to-day operations and educational and marketing support. The Company has operations in the United States and the United Kingdom.

Note 2—Summary of Significant Accounting Policies

Basis of Presentation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.

Unaudited Financial Statements

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-QSB and Article S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

Cash and Cash Equivalents

The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.

Property, Equipment and Leasehold Improvements

Property and equipment are recorded at cost less depreciation and amortization. Depreciation and amortization are accounted for on the straight-line method based on estimated useful lives. The amortization of leasehold improvements is based on the shorter of the lease term or the life of the improvement. Betterments and large renewals, which extend the life of an asset, are capitalized; whereas, maintenance and repairs and small renewals are expensed as incurred.

Foreign Currency Translation

The financial statements of all foreign subsidiaries were prepared in their respective local currencies and translated into U.S. dollars based on the current exchange rate at the end of the period for the balance sheet and a weighted-average rate for the period on the statement of operations. Translation adjustments are reflected as foreign currency translation adjustments in shareholders’ equity and accordingly have no effect on net loss.

Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

7

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Advertising

Advertising costs incurred for major new campaigns are expensed in the year in which the advertising takes place. Other advertising costs are expensed when incurred. Advertising expense for the three and nine months ended March 31, 2002 was $12,126 and $74,524, respectively and for the three and nine months ended March 31, 2001, was $12,999 and $183,852, respectively.

Income Taxes

The Company accounts for income taxes under Statement of Financial Accounting Standards No. 109, “Accounting for Income Taxes.” This statement requires an asset and liability approach to account for income taxes. The Company provides deferred income taxes for temporary differences that will result in taxable or deductible amounts in future years based on the reporting of certain costs in different periods for financial and income tax purposes.

Stock Option Plans

The Company has adopted SFAS No. 123 “Accounting for Stock-Based Compensation,” which permits entities to recognize as expense over the vesting period the fair value of all stock-based awards on the date of grant. Alternatively, SFAS No. 123 also allows entities to continue to apply the provisions of APB Opinion No. 25 “Accounting for Stock Issued to Employees,” and provide pro forma net income and pro forma earnings per share disclosures for employee stock option grants as if the fair-value-based method defined in SFAS No. 123 has been applied. The Company has elected to apply the provisions of APB Opinion No. 25 and provide the pro forma disclosure provisions of SFAS No. 123.

Reclassifications

Certain prior period amounts have been reclassified to conform to March 31, 2002 presentation. These changes had no impact on previously reported results of operations or shareholders’ equity.

Note 3—Acquisitions

Mobile PET Systems, Inc. was incorporated in the State of Nevada on December 1, 1998. On December 22, 1998, Mobile P.E.T Systems, Inc.’s shareholders exchanged all of the 7,000,000 shares of outstanding common stock for 7,000,000 shares of common stock in Colony International Incorporated, (formerly American Coin and Stamp, Inc.), incorporated in the State of Delaware on August 21, 1995 and its wholly owned subsidiary Colony International Incorporated, incorporated in the State of Nevada on April 25, 1995. This exchange of shares was accounted for as a reverse merger, under the purchase method of accounting. Accordingly, the combination of the Mobile PET Systems, Inc. and Colony International Incorporated and subsidiary was recorded as a recapitalization of the shareholders’ equity of Mobile PET Systems, Inc., the surviving corporation and for accounting purposes the financial statements presented are those of Mobile PET Systems, Inc.

On December 10, 1999, the Company incorporated a wholly owned subsidiary, The London PET Centre Limited, a United Kingdom private limited company. On December 17, 1999 the Company incorporated two wholly owned subsidiaries, Mobile PET Leasing Limited, a United Kingdom private limited company and Mobile PET Systems (UK) Limited, a United Kingdom private limited company. Mobile PET Systems (UK) Limited is currently inactive.

On March 15, 2001, the Company incorporated a wholly owned subsidiary, Radiodiagnostics Corporation, a Nevada corporation.

8

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

On March 25, 2002, the Company formed wholly owned subsidiaries, MBPT #3 LLC and MBPT #4 LLC, Delaware Limited Liability Companies and on April 3, 2002, the Company formed wholly owned subsidiaries, MBPT #1 LLC and MBPT #2 LLC, California Limited Liability Companies for the purpose of providing fixed site PET services. These Limited Liability Companies are currently inactive.

Note 4—Prepaid Expenses and Other Receivables

Prepaid expenses consist of the following at March 31, 2002 and 2001:

	March 31,
	2002		2001
Prepaid equipment rent	$	547,990	$	88,106
Other		231,660		146,660
	$	779,650	$	234,766

Note 5—Property and Equipment

Property and equipment at March 31, 2002 and 2001 consist of the following:

	March 31,
	2002			2001
Computer equipment	$	698,712		$	462,468
Office furniture and fixtures		185,007			43,572
Office equipment		43,284			41,113
Leasehold improvements		7,071			—
Equipment		19,830,221			19,531,880
		20,764,295			20,079,033
Less accumulated depreciation		(5,096,471	)		(2,045,546	)
	$	15,667,824		$	18,033,487

Depreciation expense for the three and nine months ended March 31, 2002 was $763,413 and $2,277,766, respectively and for the three and nine months ended March 31, 2001 was $741,586 and $1,583,108, respectively.

Note 6—Deposits and Other Assets

Deposits and other assets consist of the following at March 31, 2002 and 2001:

	March 31,
	2002		2001
Equipment deposits—Mobile PET Units	$	388,130	$	688,891
Equipment rental deposits—other		49,000		49,000
Lease deposits		5,000		13,955
Preferred stock redemption deposit		500,000		—
Other		88,481		90,770
	$	1,030,611	$	842,616

Equipment deposits—Mobile PET Units are refundable upon the Company securing lease financing or may be applied to subsequent equipment orders.

9

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 7—Capitalization

Preferred Stock

On January 20, 2000, the Company authorized for issuance ten million (10,000,000) shares of preferred stock having one hundredth of a cent ($0.0001) par value per share. On March 3, 2000 the Company designated and issued sixty (60) shares 8% Cumulative Convertible Redeemable Preferred, Series A Stock (“Series A”) for cash in the amount of $2,700,000, net of acquisition fees. In addition, under this Securities Purchase Agreement the Company issued 120,000 warrants to purchase shares of common stock at an exercise price of $5 per share, which expire in March 2003. The shares of Series A Stock have no voting rights, have an original liquidation value of $50,000 per share, and accrue dividends at a rate of eight percent (8%) per annum per share on the liquidation value payable upon conversion. On May 30, 2001 the liquidation value was increased to $58,937 when the Company entered into a Settlement Agreement and Conditional Release of a lawsuit surrounding the Securities Purchase Agreement. The total liquidation value of the shares outstanding at March 31, 2002 and 2001 in the amount of $1,351,030 and $1,975,000, respectively is classified on the Company’s balance sheet as preferred stock. Cumulative preferred dividends are payable upon conversion and at March 31, 2002 there are cumulative preferred dividends in arrears in the amount of $165,137 or $7,180 per share. In the event of any liquidation, dissolution or winding up of the affairs of the Company, holders of the Series A Stock shall be paid the liquidation value plus all accrued dividends at that date before any payment to other shareholders. At the option of the holders, the Series A Stock and the cumulative preferred dividends in arrears are convertible into shares of common stock determined by dividing $58,937 by the conversion price of the lesser of $5 or 75% of the average of the closing bid price of common stock during the five (5) trading days immediately prior to the conversion date. If the Company fails to convert or is unable to issue shares of common stock, the holder may redeem the Series A Stock for cash in an amount equal to the fair value of the shares of common stock that would have been converted. The sixty (60) shares of Series A Stock provide an intrinsic value of beneficial conversion feature of approximately $1,206,000. As of March 31, 2002, the holders converted thirty-seven (37) shares of Series A into 3,431,783 shares of common stock. At March 31, 2002 there are twenty-three (23) shares of Series A issued and outstanding.

On September 21, 2000, the Company designated and subsequently issued thirty (30) shares 8% Cumulative Convertible Redeemable Preferred, Series B Stock (“Series B”) for cash in the amount of $1,385,000, net of acquisition fees. In addition, under this Securities Purchase Agreement the Company issued 50,000 warrants to purchase shares of common stock at an exercise price of $3 per share and 29,851 warrants to purchase shares of common stock at an exercise price of $2.5125 per share. The warrants expire on September 30, 2005. The shares of Series B Stock have no voting rights, have an original liquidation value of $50,000 per share, and accrue dividends at a rate of eight percent (8%) per annum per share on the liquidation value payable upon conversion. On May 30, 2001 the liquidation value was increased to $58,937 when the Company entered into a Settlement Agreement and Conditional Release of a lawsuit surrounding the Securities Purchase Agreement. The total liquidation value of the shares outstanding at March 31, 2002 and 2001 in the amount of $1,768,103 and $1,500,000, respectively is classified on the Company’s balance sheet as preferred stock. Cumulative preferred dividends are payable upon conversion and at March 31, 2002 there are cumulative preferred dividends in arrears in the amount of $112,808 or $3,760 per share. In the event of any liquidation, dissolution or winding up of the affairs of the Company, holders of the Series B Stock shall be paid, pari passu with holders of the Series A Stock, the liquidation value plus all accrued dividends at the date of liquidation, dissolution or winding up of the affairs before any payment to other shareholders. At the option of the holders, the Series B Stock and the cumulative preferred dividends in arrears are convertible into shares of common stock determined by dividing $58,937 by the conversion price of the lesser of $3 or 75% of the average of the closing bid price of common stock during the five (5) trading days immediately prior to the conversion date. If the Company fails to convert or is unable to issue shares of common stock, the holder may redeem the Series B Stock for cash in an

10

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

amount equal to the fair value of the shares of common stock that would have been converted. The thirty (30) shares of Series B Stock issued provide an intrinsic value of beneficial conversion feature of approximately $414,580.

Common Stock

The Company has authorized for issuance ninety million (90,000,000) shares of common stock, having one hundredth of a cent ($0.0001) par value per share. On June 30, 2000 the Company had 14,944,658 shares of common stock issued and outstanding.

During the nine months ended March 31, 2001 the Company issued shares of common stock in cash transactions: 1,615,584 shares for cash in the amount of $872,500. Also during the nine months ended March 31, 2001 the Company issued shares of common stock in non-cash transactions: 1,080,686 shares through the conversion of Series A Stock valued at $1,025,000; and 75,356 shares through the conversion of Series A Stock dividends in arrears valued at $66,274.

During the three months ended June 30, 2001 the Company issued shares of common stock in cash transactions: 2,147,578 shares for cash in the amount of $996,150; and 2,733,981 shares for cash in the amount of $750,000 according to the terms of a settlement agreement between the Company and holders of the Series A and Series B Stock. Also during the three months ended June 30, 2001 the Company issued shares of common stock in non-cash transactions: 607,893 shares through the conversion of Series A Stock valued at $295,035; 1,875,000 shares through the conversion of debt valued at $750,000; and 403,350 shares for legal services valued at $201,675. On June 30, 2001 the Company had 25,484,086 shares of common stock issued and outstanding.

During the nine months ended March 31, 2002 the Company issued shares of common stock in cash transactions: 2,600,000 shares from paid subscriptions at June 30, 2001 in the amount of $1,000,000; 8,671,427 shares for cash in the amount of $3,275,000. Also during the nine months ended March 31, 2002 the Company issued shares of common stock in non-cash transactions: 1,743,204 shares through the conversion of Series A Stock valued at $682,288; 161,714 shares as a finders fee; 100,000 shares as compensation valued at $43,000; and 3,062,331 shares for services valued at $1,060,251. On March 31, 2002 the Company had 41,822,762 shares of common stock issued and outstanding and subscriptions paid in the amount of $500,000 for the issue of an additional 1,428,571 shares of common stock.

Stock Options

The Company’s Board of Directors and shareholders adopted the 1999 Stock Option Plan pursuant to which incentive stock options or nonstatutory stock options to purchase up to 8,000,000 shares of common stock may be granted to employees, directors and consultants. Stock options generally expire on June 30, 2002, with some options extending to September 12, 2005 and vesting over service periods that range from zero to four years.

11

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

As of March 31, 2002, the Company has granted options to purchase 4,329,501 shares of common stock as follows:

	Exercise Price	Number of Shares		Vested Shares
Outstanding, June 30, 2000	$1.00 – $4.63	5,988,000		2,644,500
Granted	$2.00 – $3.75	483,750		—
Exercised	$1.90	(25,000	)	(25,000	)
Cancelled		—		—
Outstanding, September 30, 2000	$1.00 – $4.63	6,446,750		2,619,500
Granted	$1.26 – $3.42	534,500		585,000
Exercised		—		—
Cancelled	$1.70 – $3.75	(330,000	)	(120,000	)
Outstanding, December 31, 2000	$1.00 – $4.63	6,651,250		3,084,500
Granted	$  .45 – $1.09	134,000		313,166
Exercised		—		—
Cancelled	$1.26 – $3.60	(1,225,000	)	(178,332	)
Outstanding, March 31, 2001	$  .45 – $4.63	5,560,250		3,219,334
Granted	$  .60 – $2.76	130,000		419,336
Exercised		—		—
Cancelled	$1.26 – $3.77	(809,500	)	(215,000	)
Outstanding, June 30, 2001	$  .45 – $4.63	4,880,750		3,423,670
Granted	$  .43 – $2.00	1,621,876		1,173,707
Exercised		—		—
Cancelled	$1.00 – $4.63	(550.833	)	(355,834	)
Outstanding, September 30, 2001	$  .43 – $3.75	5,951,793		4,241,543
Granted	$  .52 – $1.00	229,167		336,000
Exercised		—		—
Cancelled	$  .56 – $3.13	(884,834	)	(853,667	)
Outstanding, December 31, 2001	$  .43 – $3.75	5,296,126		3,723,876
Granted		—		411,834
Exercised		—		—
Cancelled	$  .45 – $3.13	(966,625	)	(697,541	)
Outstanding, March 31, 2002	$  .43 – $3.75	4,329,501		3,438,169

The Company accounts for stock-based compensation using the intrinsic value method prescribed by Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees,” under which no compensation cost for stock options is recognized for the stock option awards granted at or above fair market value. However, during the nine months ended March 31, 2002 and 2001 the Company recognized a noncash (credit) charge using the intrinsic value method of $(495,560) and $624,192, respectively.

Warrants

At March 31, 2002 warrants were outstanding to purchase 10,825,808 common stock at exercise prices between $0.35 to $7.00 per share, and at the average of the last reported sale price of the common stock for the five trading days preceding the issue date. These warrants expire between April 10, 2002 and May 25, 2006.

12

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 8—Related Party Transactions

Subordinated Equity Participation

During the nine months ended March 31, 2001, the Company entered into a Memorandum of Agreement and retroactive to June 1, 1999 restructured an 8% interest in a subordinated equity participation in London Radiosurgical Centre Ltd (“LRC”), a foreign corporation with a common shareholder, officer and director. The market value of the subordinated equity participation is not readily determinable, and is recorded at cost in the amount of $200,000, which management believes approximates fair value. The original agreement provided for distributions of cash, if any, including interest at a rate of 15% per annum, up to the amount of the investment plus accrued interest, after which the Company was to receive its proportionate share of 60% of net distributable income. According to the terms of the participation agreement, net income available for distribution is equal to net income less equipment financing payments, operating expenses, reserve capital and taxes.

The Memorandum of Agreement provides for a distribution to the Company of 8.42% of LRC’s net distributable cash flow, until a total of $210,573 has been distributed and then the distribution of 5.05% of net distributable cash flow, subject to future dilution. The Memorandum of Agreement stopped the accrual of interest at June 1, 1999. At the date of the Memorandum of Agreement, the Company canceled $47,447 of accrued interest from the original investment and at March 31, 2002 and 2001 accrued interest on the investment was $10,573. The related shareholder, officer and director personally guarantee the investment.

Due from London Radiosurgical Centre, Ltd

LRC provides office space and administrative expenses under normal commercial terms to The London PET Centre Limited. The London PET Centre Limited made cash payments of approximately $0 and $1,100 to LRC and office space and administrative expense was approximately $170,766 and $125,300 during the nine months ended March 31, 2002 and 2001, respectively. During the nine months ended March 31, 2002 and 2001, the Company advanced without interest $0 and $708, respectively to LRC for working capital during LRC’s start-up period. The advances are covered by a continuing corporate and personal guarantee. There is a balance due from London Radiosurgical Centre, Ltd in the amount of $152,294 and $252,369 at March 31, 2002 and 2001, respectively.

Loans

On August 23, 2000, the Company received an eight percent (8%) bridge loan from a director and shareholder in the amount of $200,000, with an original due date of October 11, 2000. The loan’s due date has been extended several times and the Company has agreed to make monthly payments of $10,000 per month beginning on January 8, 2002, until paid in full. At March 31, 2002 and 2001, the loan has a balance of $170,000 and $200,000, respectively and accrued interest of $0 and $9,600, respectively.

On October 24 2000, the Company received an eight percent (8%) bridge loan from an officer, director and shareholder in the amount of $100,000, which was due on or before November 30, 2000. The loan was extended to June 1, 2001. In October 2000, an eight percent (8%) promissory note was issued in the amount of $100,000 in exchange for the loan. Principal, plus accrued interest is payable in installments: $20,000, plus accrued interest on October 8, 2001 and $10,000 plus accrued interest on the first day of each successive month, until paid in full. At March 31, 2002 and 2001, the loan has a balance of $20,000 and $100,000, respectively, plus accrued interest of $0 and $3,463, respectively.

On January 12, 2001, the Company received an eight percent (8%) bridge loan from an officer, director and shareholder in the amount of $25,000, with an original due date of March 12, 2001, and extended to December 1, 2001. The loan was paid in December 2001.

13

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

On January 17, 2001, the Company received an eight percent (8%) bridge loan from an officer, director and shareholder in the amount of $150,000, with an original due date of March 12, 2001. The note has been extended several times and is now due on March 1, 2002. The note is past due. At March 31, 2002, accrued interest is $0.

On February 5, 2001, the Company received an eight and one-half percent (8.5%) bridge loan from a shareholder in the amount of $500,000. At the option of the holder, the principal and accrued interest was convertible into shares of common stock at a conversion price of $1 per share. The option had a beneficial conversion feature in the amount of $7,800 which was recorded as debt discount and amortized as interest expense through the date the option expired. The option expired on March 22, 2001. On March 20, 2001, the Company received an additional bridge loan in the amount of $250,000, cancelled the note dated February 5, 2001 in the amount of $500,000, and issued a new convertible ten percent (10%) note in the amount of $750,000. At March 31, 2001 the balance of the note was $750,000, plus accrued interest in the amount of $7,267. At the option of the holder, the principal and accrued interest is convertible into shares of common stock at a conversion price of $.40 per share. The new loan did not have a beneficial conversion feature. On June 14, 2001 the holder converted the note into 1,875,000 shares of common stock.

On October 12, 2001, the Company converted $253,050 due to a director into a promissory note without interest and payable in monthly installments of $14,000 per month beginning on October 15, 2001, until paid in full. At March 31, 2002, the loan has a balance of $169,050.

Note 9—Securities Purchase Agreement

On March 3, 2000, the Company entered into a Securities Purchase Agreement, pursuant to which the Company issued 60 shares of 8% Cumulative Convertible Redeemable Preferred, Series A Stock for cash in the amount of $2,700,000, net of acquisition fees and 120,000 warrants to purchase shares of common stock at an exercise price of $5.00 per share, which expire in March 2003. The buyer of the preferred stock agreed to purchase shares of common stock of the Company in tranches, for an aggregate purchase price of up to $10,000,000, at a price equal to eighty five percent (85%) of the average closing bid price five (5) consecutive days immediately prior to the Company providing a tranche notice to the buyer. During the nine months ended March 31, 2001 the Company received $1,075,000, net of offering costs and subsequently issued 2,703,093 shares of common stock. There is an aggregate commitment remaining in the amount of $8,925,000 at March 31, 2002.

Note 10—Consulting Agreement

Effective September 21, 2001 the Company entered into a Consulting Agreement for investor relation services. On October 9, 2001 the Company issued 2,500,000 shares of common stock, restricted during the term of the Agreement, valued at $804,000 in payment for services. In addition, the Company issued options to purchase 200,000 shares of common stock at a price of $1.00 share. The options expire on September 21, 2002. The cast of the services was amortized over the estimated period benefited.

Note 11—Employment Agreements

The Company has employment and compensation agreements with key officers and employees of the Company. The agreements vary in terms providing annual salaries and options to purchase shares of common stock, which may or may not be contingent upon individual or Company stock performance.

14

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 12—Income Taxes

At March 31, 2002 the Company has a net operating loss carryforward for tax purposes of approximately $12,200,000 which expires through the year 2020. The Internal Revenue Code contains provisions, which may limit the loss carryforward available if significant changes in shareholder ownership of the Company occur.

The components of the provision for income taxes for the nine months ended March 31, 2002 and 2001 are as follows:

	March 31,
	2002		2001
Current
Foreign	$	—	$	—
Federal		—		—
State		1,600		5,897
		1,600		5,897
Deferred
Foreign		—		—
Federal		—		—
State		—		—
		—		—
Provision for income taxes	$	1,600	$	5,897

The components of the net deferred tax assets were as follows:

	March 31,
	2002			2001
Deferred tax assets
Non-cash compensation	$	266,794		$	610,782
Organization and start-up costs		91,115			155,949
State tax benefit and other		441,682			274,728
Net operating loss carryforward		5,219,573			1,876,357
		6,019,164			2,917,816
Deferred tax liabilities
Depreciation		376,292			44,688
		5,642,872			2,873,128
Less valuation allowance		(5,642,872	)		(2,873,128	)
Net deferred tax assets	$	—		$	—

15

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Note 13—Long Term Debt

Long term debt at March 31, 2002 and 2001 consists of the following:

	2002			2001
Promissory Note with interest at a rate of 11% per annum, due in monthly installments of $2,343, with the first payment beginning on January 1, 2002, with a variable 5% to 1% prepayment penalty.	$	78,431		$	108,753
Less current portion		(15,284	)		(22,711	)
Long term debt, net of current portion	$	63,147		$	86,042

The maturities of long term debt for each of the succeeding five years subsequent to March 31, 2002, are as follows:

	Twelve Months Ending March 31,
2003	$	15,284
2004		18,587
2005		24,413
2006		20,147
	$	78,431

Note 14—Commitments

Equipment under capital lease is included in property and equipment as follows:

	March 31,
	2002			2001
Equipment	$	19,830,221		$	19,277,737
Less accumulated amortization		(4,833,131	)		(1,611,101	)
Net capital lease assets	$	14,997,090		$	17,666,636

The Company leases office space and certain PET equipment under non-cancelable operating leases. The office lease expires in April 2005 and the equipment leases expire through May 2006.

Rent expense for the three and nine months ended March 31, 2002 was $433,181 and $1,174,042, respectively and for the three and nine months ended March 31, 2001 was $9,090 and $56,699.

The Company leases certain other PET equipment under capital leases. The equipment leases expire through March 2006. The capital leases are secured by the Company’s assets. The chief executive officer of the Company has personally guaranteed one lease. Certain leases contain covenants that restrict the use of cash and require the Company to maintain financial ratios. The Company has been advised of its failure to maintain a debt service coverage ratio of not less than 1.25 to 1.00, placing three leases in default. The Company has also been advised three other lease agreements are in default for failure to make lease payments when due and demand has been made for payment of $2,294,394. Obligations under capital lease—current include $6,755,479 of lease obligations currently in default.

16

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following is a schedule by year of the future minimum lease payments at March 31, 2002:

Twelve Months Ending March 31,	Capital Lease			Operating Leases
2003	$	11,838,599		$	1,196,750
2004		3,403,572			1,220,130
2005		3,403,572			1,104,364
2006		2,666,242			1,063,034
2007		—			88,940
		21,311,985		$	4,673,218
Less amount representing interest at 12.07%		(7,268,434	)
Present value of minimum lease payments (including current portion of $8,523,552)	$	14,043,551

Note 15—Concentration of Credit Risk

The Company maintains cash with various major financial institutions in excess of the Federal Deposit Insurance Corporation limits.

Note 16—Earnings (Loss) Per Share

The computations of basic and diluted earnings per share from continuing operations for the nine months ended March 31, 2002 and 2001 were as follows:

	March 31,
	2002			2001
Loss per share—basic
Numerator:
Net loss—available to Common shareholders	$	(3,718,936	)	$	(8,102,995	)
Denominator:
Weighted-average shares		31,351,109			15,693,489
Net loss per share—available to Common shareholders—basic	$	(0.12	)	$	(0.52	)
Loss per share—diluted
Numerator:
Net loss—available to Common shareholders	$	(3,718,936	)	$	(8,102,995	)
Denominator:
Weighted-average shares		31,351,109			15,693,489
Net loss per share—available to Common shareholders—diluted	$	(0.12	)		(0.52	)

17

MOBILE PET SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The average shares listed below were not included in the computation of diluted loss per share because to do so would have been antidilutive for the nine months ended March 31, 2002 and 2001:

	March 31,
	2002	2001
Cumulative convertible redeemable preferred stock common stock equivalent	936,378	755,900
Employee stock options	6,149,441	4,869,385
Warrants	5,780,835	1,156,547

Note 17—Prior Period Adjustments

The financial statements as of March 31, 2001 and for the three and nine months then ended have been restated. This restatement (i) corrects the reported value of certain stock compensation, (ii) records a noncash credit for options forfeited, and (iii) re-classifies certain expenses between selling and marketing expense, and general and administrative expense. The effect of the restatements are as follows:

	For the three months ended March 31, 2002						For the nine months ended March 31, 2002
	As Previously Reported			As Restated			As Previously Reported			As Restated
Statement of operations:
Service revenues	$	4,599,403		$	4,599,403		$	12,427,453		$	12,427,453
Cost of services revenues		(2,857,882	)		(2,885,556	)		(7,473,849	)		(7,504,646	)
Selling and marketing		(635,396	)		(363,637	)		(2,399,010	)		(1,134,555	)
General and administrative		(1,640,314	)		(1,979,766	)		(4,691,367	)		(5,645,185	)
Other income (expense)		(519,805	)		(532,205	)		(1,620,690	)		(1,646,098	)
Provision for income taxes		(12,400	)		—			(26,414	)		(1,600	)
Preferred stock dividend		(61,618	)		(61,618	)		(214,305	)		(214,305	)
Net loss—available to common shareholders	$	(1,128,012	)	$	(1,223,379	)	$	(3,998,182	)	$	(3,718,936	)
Net loss—available to common shareholders—basic	$	(0.03	)	$	(0.03	)	$	(0.13	)	$	(0.12	)
Net loss—available to common shareholders—diluted	$	(0.03	)	$	(0.03	)	$	(0.13	)	$	(0.12	)

Note 18—Subsequent Events

On April 4, 2002 the Company issued 1,000,000 shares of common stock for cash in the amount $350,000 with a warrant to purchase 500,000 shares of common stock at a price of thirty-five cents ($0.35) per share. The warrant expires on April 3, 2003.

On April 10, 2002 the Company received a notice of conversion for three (3) shares of Series B preferred stock to be converted into 414,934 shares of common stock.

On April 23, 2002 the Company issued 1,428,571 shares of common stock for cash in the amount $500,000 with a warrant to purchase 714,286 shares of common stock at a price of thirty-five cents ($0.35) per share. The warrant expires on March 27, 2004.

On April 30, 2002 the Company issued 300,000 shares of common stock for cash in the amount $105,000 with a warrant to purchase 150,000 shares of common stock at a price of thirty-five cents ($0.35) per share. The warrant expires on April 30, 2003.

18

Item 2.    Management’s Discussion and Analysis

Overview

Mobile PET Systems, Inc. is a medical service provider of Positron Emission Tomography (PET) imaging services to hospitals and healthcare professionals in the United States and United Kingdom. PET is a molecular imaging procedure used to diagnose and stage cancer, heart disease and neurological deficits. Our medical service business enables hospitals and other healthcare professionals the ability to access, offer and provide this advanced diagnostic imaging patient service efficiently and with little risk.

We provide hospitals and physicians access under a service agreement to our state-of-the-art PET imaging systems, which are integrated into mobile coaches or in a stationary PET facility. We provide licensed technical personnel to operate the equipment and perform the technical PET imaging procedure, daily operations and logistical management, marketing, education and peripheral support services. All patient imaging procedures are implemented under the direction of a licensed staff physician who is provided by the medical institution.

As of March 31, 2002 we were providing our services to over 75 accounts, which consisted of hospitals and physicians in the United States. We also operated a wholly owned subsidiary, The London PET Centre Ltd., which is the only private sector stationary PET facility in the United Kingdom. We believe there are and will be significant opportunities to develop and operate additional mobile and stationary PET facilities in the United States, United Kingdom and in key European markets.

We have measured the financial position and results of operations of our United Kingdom subsidiaries using local currency as the functional currency. We have translated our assets and liabilities into U.S. dollars at the rates of exchange at the balance sheet date. We have translated our statements of operations using the average exchange rates prevailing throughout the reporting period. We have accumulated the translation gains or losses resulting from the changes in the exchange rates from quarter-to-quarter in a separate component of shareholders equity. We have reflected the transaction gains and losses in the cash flow as the effect of exchange rate changes on cash.

Results of Operations

For the three and nine months ended March 31, 2002, we had fifteen mobile units and one fixed site accepted and placed into service, generating revenues for the three and nine months ending March 31, 2002 of $4,559,403 and $12,427,453 compared to the three and nine months ending March 31, 2001, in which we had revenues of $2,308,196 and $4,267,864, respectively. Our costs of service for the three and nine months ending March 31, 2002 were $2,885,556 and $7,504,646 compared to $1,452,592 and $3,197,848 for the three and nine months ending March 31, 2001. This substantial difference in revenues and costs is largely attributable to the number of units which were in service during the applicable periods. As a result of these activities, accounts receivables increased to $2,853,117 net of allowances for doubtful accounts, as of March 31, 2002, as compared to accounts receivables of $2,225,351, net of allowances for doubtful accounts, as of March 31, 2001. The costs of service revenues represent salaries paid to technologists and drivers, system maintenance, transportation and insurance on our mobile PET systems. We have transitioned from a development stage company and are now seeking to grow. Prior to this transition, our efforts have been principally focused on capitalization, organizational and business development activities.

We continue our efforts to develop and expand our service business by increasing utilization of our existing units, and developing and operating additional mobile and stationary PET systems. We anticipate we may continue to incur additional losses as we pursue our development efforts. If we continue our unit growth and achieve targeted unit revenues, we believe cash flow will be sufficient to cover our cost of services on a monthly basis.

19

Our future revenues will principally be a function of the number of operating units in service, the volume of patient procedures and the fees earned per procedure. We generate substantially all our revenues from our service agreements with hospitals and other health care providers. We have a satisfactory record of account collections, however there can be no assurance that this trend will continue and, accordingly, we have established an allowance for uncollectable accounts receivable. Lower reimbursement by public and private insurers may also impact the revenues the Company can generate from its operations. There can be no assurance that we will be able to maintain or increase the number of patient procedures.

Since our inception we have incurred significant losses. Through March 31, 2002, we have incurred a net deficit of $21,872,428, which we have financed primarily through equity sales. For the three and nine months ended March 31, 2002, we experienced a consolidated loss from operations of $629,556 and $1,856,933, compared to a consolidated loss from operations of $1,286,780 for the three months, and $5,817,171 for the nine months ended March 31, 2001. Our net loss available to common shareholders, after preferred stock dividend, was $1,233,379 for the three months and $3,718,936 for the nine months ended March 31, 2002, compared to the net loss available to common shareholders of $1,992,113 for the three months and $8,102,995 for the nine months ended March 31, 2001.

We expensed as a non-cash transaction the issuance of 2,500,000 shares to our investor relations company American Financial Corporation. This resulted in a non-cash expense of $212,333 for the three months and $804,000 for the nine months ended March 31, 2002. We have implemented cost reductions by reducing administrative and travel expense and by negotiating higher discounts for new equipment, service and radiotracers. Subject to obtaining additional financing, we are also seeking to deploy additional mobile units or stationary sites which will reduce per unit operating costs. However, we can give no assurances that our efforts will have the desired effects. As a result, in order to achieve and maintain profitability, we will need to continue to increase revenues and effectively manage our operating overhead.

Selling expenses for the three months and nine months ended March 31, 2002 were $363,637 for the three months and $1,134,555 for the nine months, as compared to $978,017 for the three months and $2,740,637 for the nine months ended March 31, 2001. The decrease resulted from a substantial reduction in our sales force. General and Administrative expenses for the three months and nine months ended March 31, 2002 were $1,979,766 for the three months and $5,645,185 for the nine months ended March 31 2002, as compared to $1,164,367 for the three months and $4,146,550 for the nine months ended March 31, 2001. The primary reason for the increase was charges related to common stock issued for services, as described above. The principal components of our operating costs consist of equipment leasing, equipment service and maintenance, salaries and benefits, legal and accounting fees, insurance and transportation costs. Because the majority of these costs are fixed, increased revenues as a result of increased patient procedures may provide higher profitability, while lower patient procedures may result in lower profitability.

Depreciation expense increased from $741,586 for the three months and $1,583,108 for the nine months ended March, 2001 to $763,413 for the three months and $2,277,766 for the nine months ended March 31, 2002 mainly due to the increase in mobile PET units deployed to fifteen mobile and one fixed site at March 31, 2002 compared to twelve mobile units and one fixed site at March 31, 2001. In addition, we continue to incur costs in building our infrastructure and incur costs in connection with business development advertising and marketing our mobile PET services.

Our interest income was $1,639 and $6,765 for the three months and nine months ended March 31 2002, respectively as compared to $4,058 and $29,047 for the three and nine months ended March 31, 2001 respectively. This was the result of a reduction of cash reserves earning interest during the later periods. Our interest expense was $521,444 and $1,628,265 for the three and nine months ended March 31, 2002, as compared to the interest expense of $676,196 and $1,620,831 for the three and nine months ended March 31, 2001.

20

Liquidity and Capital Resources

At March 31, 2002, our total assets were $21,376,934 compared to $22,143,033 at March 31, 2001. Our current assets at March 31, 2002 totaled $4,994,548 and our current liabilities were $15,040,294, as compared to current assets of $3,304,824 and current liabilities of $8,600,104 at March 31, 2001. Shareholders’ equity at March 31, 2002 increased from ($1,405,094) to $753,494.

Our foreign currency translation adjustment in shareholders’ equity amounted to ($272,779) at March 31, 2002 compared to ($41,684) at March 31, 2001. We have reflected the transaction gains and losses in the cash flow as the effect of exchange rate changes on cash of $95,272 for the three months and $47,578 for the nine months ended March 31, 2002, compared to ($102,957) for the three months and $1,254 for the nine months ended March 31, 2001.

Our net cash used in investing activities for the three and nine months ended March 31, 2002 was ($103,988) and ($236,598), respectively, as compared to ($0) and ($162,966) in the three and nine months ended March 31, 2001 respectively. This difference is primarily a result of our investment in computers and related equipment for our business and personnel growth.

The net cash provided by our financing activities for the three and nine months ended March 31, 2002 was ($1,123,765), and ($390,437), respectively, resulting mainly from the issuance of common stock of $1,250,000 during the three months and $3,775,000 during the nine months ended March 31, 2002, compared to $325,000 issued for the three months and $872,500 for the nine months ended March 31, 2001 and the payments on obligations under capital lease for the three and nine months ended March 31, 2002 being ($2,315,544) for the three months and ($4,009,442) for the nine months compared to ($0) for the three months and ($514,659) for the nine months ended March 31, 2001.

We raised $1,250,000 during the three months and $3,775,000 during the nine months ended March 31, 2002 through private placements of common stock and warrants to purchase common stock, compared to $325,000 for the three months and $2,257,500 for the nine months ended March 31, 2001, through private placements of preferred and common stock and warrants to purchase common stock.

As an additional potential source of funds if needed, we are entitled to put to York, LLC, up to a total of $10,000,000 of common stock from time to time (but not after November 2003) under the Securities Purchase Agreement for the sale of our Series A Preferred Stock subject to certain conditions set forth in that agreement. As of December 31, 2001, we have already drawn $1,820,000 against this put-equity line (for 3,950,565 common shares). All of these draws occurred on or before June 1, 2001. The per common share price of such a sale is 85% of the average closing bid price for the 5 consecutive trading days prior to the date of the sale. We have the choice to elect to use an alternative pricing period that is the three trading days on which the closing bid price of our common stock is the lowest during the number of trading days before the closing date for a sale of such shares, determined by dividing the dollar amount by 15% of the average daily dollar trading volume of our common stock for the 20 trading days before the date of our notice to York, LLC. We must wait 30 days after the closing date of a sale for which we use this alternative pricing period before we can give York another notice of sale under this provision.

Factors That May Affect Future Results

The discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the related notes. This Quarterly Report on Form 10-QSB contains forward-looking statements based upon current expectations that involve risks and uncertainties, including those identified below. For this purpose, any statements contained in it that are not statements of historical fact should be regarded as forward-looking statements within the meaning of the Act and the Exchange Act. For example,

21

the words “believes,” “anticipates,” “plans,” “intends,” “will,” “may” and “expects,” or any variation of these words including the negative of these words, are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statement contained herein, which speak only as of the date hereof. We undertake no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unexpected events.

We have lost money in the past and may lose money in the future.

We have incurred significant losses since our formation. In two recent months we have been successful in generating sufficient revenues to fund our continuing operations. In the future we may not be able to generate sufficient revenues from sales to fund continuing operations or sustain profitability.

Our substantial indebtedness could restrict our operations and make us more vulnerable to adverse economic conditions.

We are a highly leveraged company and our substantial indebtedness could have important consequences. For example, it could:

• make it more difficult for us to satisfy our obligations to our creditors;

• require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow to fund working capital, capital expenditures and acquisitions and for other general corporate purposes;

• increase our vulnerability to economic downturns and competitive pressures in our industry;

• increase our vulnerability to interest rate fluctuations because much of our debt is at variable interest rates;

• place us at a competitive disadvantage compared to our competitors that have less debt in relation to cash flow; and

• limit our flexibility in planning for, or reacting to, changes in our business and our industry.

Certain of our indebtedness is secured by equipment and other assets of the Company. If the Company defaults and the creditors foreclose, the Company and its operations could be materially and adversely effected.

We may be unable to generate or borrow sufficient cash to make payments on our indebtedness or to refinance our indebtedness on acceptable terms.

Our ability to make payments on our indebtedness will depend on our ability to generate cash flow in the future which, to a certain extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. In addition, future borrowings may not be available to us in an amount sufficient to enable us to pay our indebtedness or to fund our other cash needs. We may not be able to timely service all of our indebtedness.

Acceptance of our services by the medical community or by patients may not grow, which may impair our future sales and profitability.

High cost, concerns by patients and physicians relating to safety and efficacy, and the substantial acceptance of other diagnostic tools such as MRIs or CT scans may interfere with the growing acceptance of PET technology. We have a limited sales force and may need to hire additional technologists and sales and marketing personnel to grow the acceptance of PET services. We believe PET technology is now accepted as a valid diagnostic and staging tool for certain conditions, but we cannot promise this acceptance will continue to expand to other conditions.

22

If we do not remain profitable, we may not be able to continue our operations.

Our future revenues and profitability depend in part on our ability to demonstrate to hospitals the potential cost and performance advantages of the PET system over traditional diagnostic imaging systems. Our ability to experience profitability in the future will depend in part on our ability to successfully market and sell PET services on a wide scale.

The issuance of shares under outstanding convertible preferred stock may depress our stock.

Our Series A and B Convertible Preferred Stock (the “Series A and B Stock”) is convertible into shares of our common stock at floating rates based upon formulas tied to the market price of our common stock. As such, the lower our stock price is at the time the shares of Series A and B Stock convert, the more shares of our common stock will have to be issued as a result of the conversion. For example, if the market price of our common stock were to fall by 50% from present levels, the holders of Series A and B Stock would be entitled to convert such stock for twice as many shares of our common stock as they would at today’s level. The conversion of such stock when our common stock price is low may greatly increase the number of outstanding shares of our common stock, which may cause our stock price to fall further. That, in turn, would allow the holders of the Series A and B Stock to convert their remaining shares into even greater amounts of our common stock. The sale of such shares could yet further depress our stock price. In addition, downward price pressure caused by the sale of shares of our common stock issued on the conversion of the Series A and B Stock could encourage short sales by the holders of the Series A and B Stock and others, placing yet more downward pressure on the price of our common stock. All of the then outstanding shares of Series A and B Convertible Preferred Stock will automatically convert to common stock in March and September of 2003, respectively.

We will need to obtain additional financing in the near future.

Our capital requirements associated with our expanding operations have been and will continue to be substantial. We will require additional financing to execute our business plan. No assurance can be given that we will be able to obtain additional financing when needed, or that, if available, such financing will be on terms acceptable to us. In any such financing, the interests of our existing security holders could be substantially diluted. If adequate funds were either not available or not available on acceptable terms, our business, revenues, financial condition and results of operations would suffer. If we raise additional funds through the issuance of equity or convertible securities, the percentage ownership of our stockholders will be reduced. Moreover, these securities may have powers, preferences and rights that are senior to those of the rights of our common stock.

We have a significant number of shares that are eligible for future sale.

Virtually all of the Company’s outstanding stock was issued and sold pursuant to exemptions from registration with the Securities and Exchange Commission and state securities agencies. These shares and shares held by our affiliates are considered “restricted securities” and may be resold pursuant to an effective registration statement or in compliance with SEC Rule 144. Rule 144 generally provides that a person holding restricted securities for one year from the date the securities were purchased from the issuer, or from an affiliate of the issuer, and fully paid, may sell limited quantities of the securities to the public without registration, provided certain public information with respect to the issuer is available. Pursuant to Rule 144, securities held by non-affiliates for more than two years may generally be sold without reference to the current public information or broker transaction requirements, or the volume limitations. A significant number of shares are currently available for resale pursuant to Rule 144 and more shares will become so in the future.

In addition, the Company has granted registration rights in connection with the sale of a significant number of its shares. The exercise of such rights would require the Company to prepare and file one or more registration statements for the resale of the Company’s shares.

23

The resale of formerly restricted shares, whether pursuant to Rule 144 or a registration statement, could have a material negative impact upon the market price for the common shares.

We depend on a small number of suppliers, the loss of which could adversely affect our business.

We purchase our PET systems from a limited group of qualified suppliers: CTI of Knoxville Tenn., Siemens Medical Systems, Inc. of Iselin N.J. and GE Medical Systems, Milwaukee, Wisc. While we believe that alternative suppliers could be found for the PET system, there can be no assurance that any supplier could be replaced in a timely manner. Any interruption in the supply and/or delivery of the PET system could materially harm our ability to expand our revenues and, thereby adversely affect our financial condition and results from operations.

We may be unable to provide adequate support to our customers, and this may adversely affect our relationship with them.

We have limited experience with widespread deployment of our products and services to a diverse customer base, and there can be no assurance that we will have adequate personnel to provide the level of support that our customers may require during initial product deployment or on an ongoing basis. An inability to provide sufficient support to our customers could have an adverse affect on our reputation and relationship with our customers, prevent us from gaining new customers, and adversely affect our business, financial condition or results of operations.

Our foreign sales are subject to risks, which could negatively affect our sales and business.

An increasing portion of our sales may be made in foreign markets. The primary risks to which we are exposed due to our foreign sales are the difficulty and expense of maintaining foreign sales distribution channels, and governmental quotas and other regulations. There is also a risk due to the effect of exchange rate changes on the foreign currency we receive.

The regulation of medical devices worldwide also continues to develop, and it is possible that new laws or regulations could be enacted, which would have an adverse effect on our business. In addition, we may experience additional difficulties in providing prompt and cost effective service of PET scans in foreign countries. We do not carry insurance against these risks. The occurrence of any one or more of these events may individually or in the aggregate have an adverse effect upon our business, financial condition and results of operations.

The PET system may become technologically obsolete and our business could be harmed.

The markets in which our PET services compete are subject to rapid technological change as well as the potential development of alternative diagnostic imaging techniques or products. These changes could render the PET system technologically or economically obsolete, or cause a reduction in the value of, or reduce the need for, PET systems. Should such change occur, there could be no assurance that we will be able to acquire the new or improved systems, which may be required to service our customers.

If we are unable to obtain additional funding our business operations will be harmed.

We believe that our available short-term assets and investment income will be sufficient to meet our operating expenses and capital expenditures through the current fiscal year. We do not know if additional financing will be available when needed, or if it is available, if it will be available on acceptable terms. Insufficient funds may prevent us from implementing our business strategy or may require us to delay, scale back or eliminate certain contracts for the provision of PET services.

24

If our client contracts are not renewed or are terminated early, our business and financial results would be harmed.

Upon expiration of our clients’ contracts, we are subject to the risk that clients will cease using our PET systems and purchase or lease their own PET systems, use our competitors’ PET systems or rely on alternate imaging technologies. None of our client contracts expired in 2001, approximately seven percent expire in 2002, twenty-two percent in 2003, seventeen percent in 2004, twenty percent in 2005 and thirty-four percent in 2006. Moreover, one-third of our client contracts permit the client, upon typically 180 days notice, to terminate the contract “without cause,” and two-thirds of our client contracts permit the client, upon typically 180 days notice, to terminate the contract if the client obtains a fixed site for a PET system. In addition, a portion of our contracts does not have minimum usage requirements.

Complying with federal and state regulations is an expensive and time-consuming process, and any failure to comply could result in substantial penalties.

We are, directly or indirectly through our clients, subject to extensive regulation by both the federal government and the states in which we conduct our business. The laws that directly or indirectly affect our ability to operate our business include the following:

• the federal Medicare and Medicaid Anti-Kickback Law, which prohibits persons from soliciting, receiving or providing remuneration, directly or indirectly, to induce either the referral of an individual, or furnishing or arranging for a good or service, for which payment may be made under federal healthcare programs such as the Medicare and Medicaid programs;

• the federal False Claims Act, which imposes civil and criminal liability on individuals and entities who submit false or fraudulent claims for payment to the government;

• the federal Health Insurance Portability and Accountability Act of 1996, which prohibits executing a scheme to defraud any healthcare benefit program, including private payers;

• the federal False Statements Statute, which prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services;

• the federal physician self-referral prohibition commonly known as the Stark Law which, in the absence of a statutory or regulatory exception, prohibits the referral of Medicare patients by a physician to an entity for the provision of certain designated health services, including MRI and other imaging services, if the physician or a member of the physician’s immediate family has an ownership interest in, or a compensation arrangement with, the entity;

• state law equivalents of the foregoing;

• state laws that prohibit the practice of medicine by non-physicians and fee-splitting arrangements between physicians and non-physicians; and

• federal and state laws governing the diagnostic imaging equipment we use in our business concerning patient safety, equipment operating specifications and radiation exposure levels.

25

If our operations are found to be in violation of any of the laws described in this risk factor or the other governmental regulations to which our clients or we are subject, we may be subject to the applicable penalty associated with the violation, including civil and criminal penalties, damages, fines and the curtailment of our operations. Any penalties, damages, fines or curtailment of our operations would adversely affect our ability to operate our business and our financial results. The risk of our being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts and their provisions are open to a variety of interpretations. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management’s attention from the operation of our business.

The loss of any of our key managers could adversely affect our business, including our ability to develop and market our products.

We depend to a considerable degree on a limited number of key personnel. The loss of the services of key members of our management could harm our business. Our success will also depend, among other factors, on the successful recruitment and retention of qualified sales persons, technologists and other personnel. It is impossible to predict the availability of qualified sales persons and technologists or the compensation levels that will be required to hire them. In particular, there is a very high demand for qualified technologists who are necessary to operate our systems. We may not be able to hire or retain a sufficient number of technologists, and we may be required to pay bonuses and higher salaries to our technologists, which would increase our expenses. The loss of the services of any member of our senior management or our inability to hire or retain qualified sales persons and skilled technologists at economically reasonable compensation levels could adverse affect our ability to operate and grow our business.

If we fail to compete successfully, our revenues and operating results will be adversely affected.

Many of our competitors have substantially greater financial and marketing resources and experience than us. Furthermore, we expect that other companies will enter the mobile and stationary PET market, particularly as PET systems gain increasing market acceptance. Our competitors may be able to develop technologies, procedures or products that are more effective or economical than ours, or that would render the PET system obsolete or noncompetitive. Some of our customers may be capable of providing the same services to their patients directly by purchasing or leasing their own imaging systems. In addition, the hospital industry has been experiencing a trend towards consolidation, which trend will reduce our potential customer base and increase competition for available customers.

A successful liability claim asserted against us due to a defect in the PET system in excess of our insurance coverage would harm our business.

The provision of mobile PET shared services involves the inherent risk of professional and product liability claims against us. We currently maintain commercial general liability insurance coverage in the amount of $2 million per incident and medical professional liability insurance in the amount of $2 million per incident, but this insurance is expensive, subject to various coverage exclusions and may not be obtainable in the future on terms acceptable to us. We do not know whether claims against us arising from our use of the PET system will be successfully defended or that our insurance will be sufficient to cover liabilities arising from these claims. A successful claim against us in excess of our insurance coverage could materially harm our business.

Our PET service requires the use of radioactive materials, which could subject us to regulation, related costs and delays and potential liabilities for injuries or violations of environmental, health and safety laws.

Our PET service involves the controlled storage, use and disposal of material containing radioactive isotopes. While this material has a short half-life, meaning it quickly breaks down into inert, or non-radioactive substances, using these materials presents the risk of accidental environmental contamination and physical injury.

26

We are subject to federal, state and local regulations governing the use, storage, handling and disposal of materials and waste products. Although we believe that our safety procedures for handling and disposing of these hazardous materials comply with the standards prescribed by law and regulation, we cannot completely eliminate the risk of accidental contamination or injury from those hazardous materials. In the event of an accident, we could be held liable for any damages that result, and any liability could exceed the limits or fall outside the coverage of our insurance. We may not be able to maintain insurance on acceptable terms, or at all. We could incur significant costs and the diversion of our management’s attention in order to comply with current or future environmental, health and safety laws and regulations.

There is uncertainty relating to third party reimbursement, which is critical to market acceptance of our services.

PET services are generally purchased by hospitals, which then bill various third-party payers, such as government programs, and private insurance plans, for the procedures conducted using the PET system. Third-party payers carefully review, and are increasingly challenging, the prices charged for medical products and services, and scrutinizing whether to cover new products and evaluating the level of reimbursement for covered products. While we believe that the hospitals using the PET system have generally been reimbursed, payers may deny coverage and reimbursement for the PET system if they determine that the device was not reasonable and necessary for the purpose for which it was used, was investigational or not cost-effective. As a result, we cannot assure that reimbursement from third-party payers for use of the PET system will be available or, if available, that reimbursement will not be limited. If third-party reimbursement of these procedures is not available, it will be more difficult for us to offer our services on a profitable basis. Moreover initiatives are periodically proposed which, if implemented, would have the effect of substantially decreasing reimbursement rates for diagnostic imaging services. We cannot guarantee that these or similar initiatives will not be adopted in the future. Any change in the rates of or conditions for reimbursement could substantially reduce the number of procedures for which these healthcare providers can obtain reimbursement or the amounts reimbursed to our clients for services provided by us. Because unfavorable reimbursement policies have constricted, and may continue to constrict, the profit margins of the hospitals and clinics we bill directly, we have lowered, and may continue to need to lower, our fees to retain existing clients and attract new ones. These reductions could have a significant adverse effect on our revenues and financial results by decreasing demand for our services or creating downward pricing pressure.

The impact of recently promulgated federal regulations could have a negative impact on the attractiveness of our services to some of our clients.

Recently promulgated federal regulations affect the ability of a Medicare provider such as a hospital to include a service or facility as provider-based for purposes of Medicare reimbursement. Historically, provider-based status has allowed a provider to obtain more favorable Medicare reimbursement for services like the ones we provide. While the Medicare, Medicaid and SCHIP Benefits and Improvement Act of 2000 offers some relief for facilities recognized as provider-based on October 1, 2000, under these new regulations, some of our clients may have difficulty qualifying our services for provider-based status. If a client cannot obtain provider-based status for our services, then the provider might decide not to contract or to continue to contract with us or might acquire a fixed base PET system.

The application or repeal of state certificate of need regulations could harm our business and financial results.

Some states require a certificate of need or similar regulatory approval prior to the acquisition of high-cost capital items, including diagnostic imaging systems, or provision of diagnostic imaging services by us or our clients. While currently only one of the seventeen states in which we operate requires a certificate of need, more states are adopting similar licensing requirements. In many cases, a limited number of these certificates are available in a given state. If we are unable to obtain the applicable certificate or approval or additional

27

certificates or approvals necessary to expand our operations, these regulations may limit or preclude our operations in the relevant jurisdictions. Conversely, states in which we have obtained or will obtain a certificate of need may repeal existing certificate of need regulations or liberalize exemptions from the regulations. The repeal of certificate of need regulations in states in which we have obtained a certificate of need or a certificate of need exemption would lower barriers to entry for competition in those states and could adversely affect our business.

If we fail to comply with various licensing, certification and accreditation standards, we may be subject to loss of licensing, certification or accreditation, which would adversely affect our operations.

All of the states in which we operate require that the imaging technologists that operate our systems be licensed or certified. In the healthcare industry, various types of organizations are accredited to meet certain Medicare certification requirements, expedite third-party payment, and fulfill state licensure requirements. Some managed care providers prefer to contract with accredited organizations. There can be no assurances that we will be able to obtain accreditation with the applicable organizations. Any lapse in our licenses, certifications or accreditations, or those of our technologists, could increase our costs and adversely affect our operations and financial results.

Our revenues may fluctuate or be unpredictable and this may harm our financial results.

The amount and timing of revenues that we may derive from our business will fluctuate based on, among other variables:

• variations in the rate at which clients renew their contracts; and

• changes in the number of days of service we can offer with respect to a given system due to equipment malfunctions or the seasonal factors discussed below.

In addition, we experience seasonality in the sale of our services. For example, our sales typically decline from our first fiscal quarter to our second fiscal quarter. Second and third quarter revenues are typically lower than those from the first and fourth quarters. Second quarter revenue is affected primarily by holiday and client and patient vacation schedules and inclement weather, the results of which are fewer patient scans during the period. Third quarter revenue is affected primarily by fewer calendar days and inclement weather, the results of which are fewer patient scans during the period. We may not be able to reduce our expenses, including our debt service obligations, quickly enough to respond to these declines in revenue, which would make our business difficult to operate and would harm our financial results. In addition, we may be unable to adjust our expenditures if revenues in a particular period fail to meet our expectations, which would harm our operating results for that period.

Managed care organizations may prevent healthcare providers from using our services, which would cause us to lose current and prospective clients.

Healthcare providers participating as providers under managed care plans may be required to refer diagnostic imaging tests to specific imaging service providers depending on the plan in which each covered patient is enrolled. These requirements currently inhibit healthcare providers from using our diagnostic imaging services in some cases. The proliferation of managed care may prevent an increasing number of healthcare providers from using our services in the future, which would cause our revenues to decline.

We may be unable to effectively maintain our systems or generate revenue when our systems are not working.

Timely, effective service is essential to maintaining our reputation and high utilization rates on our systems. Repairs to one of our systems can take up to two weeks and result in a loss of revenue. Our warranties and maintenance contracts do not fully compensate us for loss of revenue when our systems are not working. The

28

principal components of our operating costs include depreciation; salaries paid to technologists and drivers, annual system maintenance costs, insurance and transportation costs. Because the majority of these expenses are fixed, a reduction in the number of scans performed due to out-of-service equipment will result in lower revenues and margins. The equipment manufacturers perform repairs of our equipment for us. We cannot guarantee that these manufacturers will be able to perform repairs or supply needed parts in a timely manner. Thus, if we experience greater than anticipated system malfunctions or if we are unable to promptly obtain the service necessary to keep our systems functioning effectively, our revenues could decline and our ability to provide services would be harmed.

We have a limited operating history.

Our prospects must be considered in light of the risks, uncertainty, expenses and difficulties frequently encountered by new companies, particularly in new and rapidly evolving markets such as those for the services we provide.

We maintain cash with various banks in excess of federally insured limits.

The Federal Deposit Insurance Corporation (“FDIC”) insures deposits up to $100,000 in virtually all United States banks and savings associations. In the event an FDIC-insured bank fails and depositors lose their money, the FDIC pays depositors up to $100,000 of the money lost. Although our funds are deposited in accounts with FDIC-insured banks, the amounts of cash in these accounts exceed federally insured limits. In the event of a failure of one of our banks where our funds were lost, we could only recover from the FDIC up to $100,000 of the funds lost. The loss of the excess funds could have a material adverse effect on our business.

29

PART II.    OTHER INFORMATION

Item 1.    Legal Proceedings

As previously reported, on February 27, 2001, Twenty-Five-Forty, LLC filed suit against the Company in the Superior Court for the State of California (San Diego) for damages for breach of contract, alleging that the Company abandoned a sub-lease that the Company had entered into with Twenty-Five Forty LLC. The monthly rent under the sub-lease was $2,990, and the space was re-let by the end of May, 2001. The Company filed a cross-complaint against Twenty-Five Forty LLC for intentional and negligent misrepresentation. The cross-complaint allege, among other things, that Twenty-Five Forty LLC fraudulently induced the Company to enter into the contract and accordingly the lease contract is void.

On January 3, 2002, the Company settled this matter by agreeing to pay Twenty-Five Forty, LLC $5,000.00 and executed a promissory note for $20,000, bearing no interest, to be paid $500 per month until paid in full. Both parties also dismissed their respective complaints and executed mutual releases.

From time to time the Company becomes involved in legal proceedings, either as a plaintiff or defendant. The Company is currently involved in several such proceedings to enforce the termination provisions or minimum number of procedure provisions of its service contracts. The Company believes none of these proceedings, either alone or in the aggregate, are material.

On May 10, 2002 the Company was served with a summons and complaint, filed April 29, 2002 in the Chancery Court for Knox County, Tennessee. This action by P.E.T. NET Pharmaceuticals, Inc. seeks to recover $567,101 for failure to pay for isotopes and radiopharmaceuticals delivered pursuant to a Preferred Provider Radiopharmaceutical Supply Agreement dated June 5, 2000. The Company has informed P.E.T. NET Pharmaceuticals, Inc. in the past that the Company did not believe it was being charged in accordance with the terms of the Preferred Provider Radiopharmaceutical Supply Agreement. The Company has not yet had an opportunity to evaluate this complaint. The Company is not yet required to respond to this complaint and has not yet done so. The Company intends to take appropriate actions to protect its rights in connection with this action.

Although there is currently no pending legal proceeding, the Company has received notice, dated April 4, 2002, from Finova Capital Corporation of an Event of Default relating to certain violations of Debt Service Ratio covenants contained in Capital Equipment Leases with the Company. We are currently in negotiation to either refinance these leases with third parties or negotiate mutually acceptable waiver and modification of these Capital Equipment Leases with Finova. The Company can give no assurance such negotiation will be successful. If we are unable to refinance these leases or reach a mutually acceptable waiver and modification with Finova, Finova may foreclose on these leases, which would have a material adverse affect on the Company and its operations.

Although there is currently no pending legal proceeding, the Company has received notice, dated March 19, 2002, from Siemens Financial Services of an Event of Default relating to failure to make equipment lease payments when due. Siemens alleged approximately $1,221,000 was in arrears, and demanded payment of $2,945,394 as the accelerated total obligation due. We have been able to pay approximately $957,000 against this obligation (which continues to accrue) during April and May 2002. If we are unable to bring these amounts current and otherwise satisfy the terms of these equipment leases, as to which no assurance can be given, Seimens has the right to foreclose on these leases, which would have a material adverse affect on the Company and its obligations.

30

Item 2.    Changes in Securities

Changes in Securities.

On or about January 16, 2002 we sold an additional 500,000 shares of common stock and 250,000 warrants to purchase common stock exercisable for a period of 2 years at $0.50 per share, in reliance on Section 4(2) of the Act. The total proceeds of this offering was $250,000.

In March 2002 we sold an additional 1,428,571 shares of common stock and 714,286 warrants to purchase common stock exercisable for a period of 2 years at $0.35 per share, in reliance on Section 4(2) of the Act. The total proceeds of this offering was $500,000.

During the period from January 1, 2002 through and including March 31, 2002, we also issued 1,521,876 shares of common stock in connection with the conversion of 10 shares of Series A Convertible Preferred Stock. These conversions were in reliance on Section 4(2) of the Act. The re-sale of these common shares is the subject of an SB-2 registration statement.

On August 15, 2001, we entered into a Letter Agreement with Windsor Capital Corporation (“Windsor”), to provide financial consulting services for a period of 2 years. That agreement provides for compensation in the form of restricted stock, payable at a rate of $10,000 per month based upon the ten (10) day average price immediately prior to such payment. On March 20, 2002, we issued 136,364 additional shares of restricted common stock valued at $60,000 to Windsor at a price of $0.4399 per share in connection with that agreement, in reliance on Section 4(2) of the Act.

During the period between April 1, 2002 and April 15, 2002, we sold an additional 2,728,571 shares of common stock and 1,364,286 warrants to purchase common stock exercisable for a period of 2 years at $0.35 per shares, in reliance on Section 4(2) of the Act. The total proceeds of this offering was $955,000.

On or about April 10, 2002, we received a notice to convert three (3) shares of Series B Preferred Stock into 414,934 shares of Common Stock. These conversions were in reliance on Section 4(2) of the Act. The re-sale of these common shares is the subject of an SB-2 registration statement.

31

Item 4.    Submission of Matters to a Vote of Security Holders.

On April 5, 2002, the Company held its annual meeting at the Sheraton Suites Hotel, San Diego, California at 10:00 am. A quorum of shareholders was present in person or by proxy.

Proposal 1.

At the meeting the following directors were elected to serve until the next annual meeting or their successor is elected, by the indicated votes:

	For	Withheld
Paul Crowe	29,636,876	102,630
Robert Bush	29,738,490	1,016
Axel Steudle	29,738,506	1,000
Jeffrey Rush	29,701,506	38,000
Robert Rohe	29,700,006	39,500

No other directors currently serve.

Proposal 2.

At the same meeting, the shareholders ratified the appointment of Peterson & Co. as the Company’s independent accountants for the fiscal year ending June 30, 2002. This proposal was approved by the following vote:

For:        29,719,974

Against: 7,752

Abstain: 11,780

Item 6.    Exhibits and Reports on Form 8-K

(a)    Exhibits

Exhibit 99.1    Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished, not filed).

(b)    Reports on Form 8-K

Form 8-K filed with the SEC on April 10, 2002, covering a press release, dated April 9, 2002, announcing unaudited preliminary third quarter revenues.

32

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MOBILE PET SYSTEMS, INC.
By:	/s/    THOMAS H. INSLEY
	Thomas H. Insley Chief Financial Officer

Date:    November 26, 2002

33

CERTIFICATIONS

1.    Chief Executive Officer

I, Paul J. Crowe, certify that:

1. I have reviewed this Amendment No. 2 to quarterly report on Form 10-QSB of Mobile PET Systems, Inc.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report.

Dated: November 26, 2002	/s/    PAUL J. CROWE
	Paul J. Crowe Chief Executive Officer

2.    Chief Financial Officer

I, Thomas H. Insley, certify that:

1. I have reviewed this Amendment No. 2 to quarterly report on Form 10-QSB of Mobile PET Systems, Inc.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report.

Dated: November 26, 2002	/s/    THOMAS H. INSLEY
	Thomas H. Insley Chief Financial Officer

34